Clinical Trial Update: A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating topical FMX-101 for moderate-to-severe acne (Acne Vulgaris) has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• FMX-101

Snippet

Sponsor: Vyne Therapeutics Inc. | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2020-09-22